Verition Fund Management LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$212,079
-60.4%
11,439
-76.4%
0.00%
-71.4%
Q2 2023$536,156
+224.9%
48,477
+294.5%
0.01%
+250.0%
Q1 2023$165,028
+17.5%
12,288
+8.2%
0.00%0.0%
Q4 2022$140,437
-64.6%
11,353
-80.0%
0.00%
-50.0%
Q3 2022$396,396
+93.4%
56,840
+282.9%
0.00%0.0%
Q2 2022$205,000
-93.4%
14,844
-89.0%
0.00%
-88.6%
Q1 2021$3,117,000
+423.9%
135,032
+460.3%
0.04%
+600.0%
Q4 2020$595,000
-58.5%
24,100
-30.3%
0.01%
-82.8%
Q3 2020$1,435,000
+580.1%
34,600
+686.4%
0.03%
+314.3%
Q2 2020$211,000
-34.5%
4,400
+69.2%
0.01%
+16.7%
Q4 2019$322,000
+56.3%
2,600
+0.5%
0.01%0.0%
Q2 2019$206,000
-86.3%
2,588
-78.3%
0.01%
-88.9%
Q3 2018$1,504,000
+90.6%
11,900
+26.6%
0.05%
+12.5%
Q2 2018$789,000
+101.8%
9,400
+295.3%
0.05%
+14.3%
Q3 2016$391,000
-3.9%
2,378
+64.9%
0.04%
-10.6%
Q1 2015$407,000
-32.1%
1,442
-43.0%
0.05%
-44.7%
Q3 2014$599,0002,5290.08%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders